IGF-1 LR3 is usually pitched as a straightforward muscle-building and recovery compound. The actual animal literature on it is more mixed than that pitch suggests, including at least one result that runs the opposite direction.
What IGF-1 LR3 is
IGF-1 LR3 (long R3 insulin-like growth factor-1) is a synthetic analog of IGF-1, modified to extend its half-life and bioavailability compared to natural IGF-1, which is cleared from the body quickly.
What's actually been studied
- Body weight versus muscle, under food restriction. A study examined LR3-IGF-I in rats during food restriction and found it helped preserve body weight, but did not preserve skeletal muscle specifically. In adult rats, it actually worsened the effects of food restriction on muscle protein by increasing protein breakdown and reducing protein synthesis, a result opposite to the muscle-preserving claim it's typically marketed on (PubMed, rat study).
- Muscle protein synthesis signaling. Separate cell-culture research has examined how IGF-1 relates to muscle protein synthesis pathways more broadly, without directly testing the LR3 analog specifically (PMC, cell-culture study).
Where the evidence is thin
The specific rat study on LR3-IGF-I is the clearest direct evidence available, and its finding, better body weight preservation but not muscle preservation, and worse muscle protein turnover in adult animals, cuts against rather than supports the way this compound is usually sold. I was not able to locate controlled human trial data on IGF-1 LR3 for muscle building, recovery, or fat loss. Broader IGF-1 signaling research exists, but it doesn't substitute for direct testing of this specific long-acting analog.
The regulatory picture
IGF-1 LR3 is not FDA-approved for any use. It's sold by research chemical vendors strictly for laboratory research, not for human use.
Papa's take
This is a case where I'd actually push back harder than usual on the common marketing claim, because the most directly relevant animal study I could find reports the opposite of "preserves muscle." That doesn't mean IGF-1 LR3 definitely does nothing useful in other contexts, but it does mean the specific muscle-preservation pitch has a real study working against it, not just an absence of evidence for it.
Sources
- Insulin-like growth factor-I (IGF-I) analogue, LR(3)IGF-I, ameliorates the loss of body weight but not of skeletal muscle during food restriction, PubMed (rat study)
- Initiation of muscle protein synthesis was unrelated to simultaneously upregulated local production of IGF-1 by amino acids in non-proliferating L6 muscle cells, PMC (cell-culture study)
Sourcing for research
If you're sourcing IGF-1 LR3 for laboratory research, purity documentation matters. See my vendor comparisons for how I evaluate third-party certificates of analysis.